Magnetic Sphincter Augmentation for Gastroesophageal Reflux Disease.
Fundoplication
Gastroesophageal reflux disease
Hiatal hernia
Magnetic sphincter augmentation
Journal
Gastrointestinal endoscopy clinics of North America
ISSN: 1558-1950
Titre abrégé: Gastrointest Endosc Clin N Am
Pays: United States
ID NLM: 9202792
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
entrez:
10
3
2020
pubmed:
10
3
2020
medline:
5
11
2020
Statut:
ppublish
Résumé
Magnetic sphincter augmentation is an effective and safe surgical method for the treatment of gastroesophageal reflux disease (GERD). The device has been compared with twice-daily proton pump inhibitor therapy and laparoscopic fundoplication (in randomized trials and prospective cohort studies, respectively). Magnetic sphincter augmentation was superior to medical therapy and equivalent to surgery for the relief of GERD symptoms. Recent research focuses on implanting the device into more complex patients, such as those with larger hiatal hernias or those with Barrett's esophagus. Additional novel research topics include cost analysis and predicting and minimizing postoperative dysphagia.
Identifiants
pubmed: 32146949
pii: S1052-5157(19)30155-2
doi: 10.1016/j.giec.2019.12.010
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
325-342Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure Dr C. Dunn has nothing to disclose. Drs N. Bildzukewicz and J. Lipham are consultants for Ethicon Inc, which manufactures the LINX device.